FDA GFI, Comparability Protocols for Postapproval Changes to CMC Information in an NDA, ANDA, or BLA, 10/22 Beatrice Burtsov2022-11-16T10:27:24+00:00November 16th, 2022| About the Author: Beatrice Burtsov